In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1839 News Items found
(From left) The first four authors of the June 24 Cancer Cell study, Barry Taylor, Anuradha Gopalan, Haley Hieronymous, and Nikolaus Schultz.
Sifting Through the Prostate Cancer Genome

A team of Memorial Sloan Kettering clinicians and computational biologists have compiled the largest catalog to date of genetic alterations that occur in prostate cancer.
Study Answers Important Question about Using Carbon Nanotubes in Medicine

A multicenter study led by Memorial Sloan Kettering researchers has answered an important question about the safety of using carbon nanotubes in medicine.
Harold Varmus former CEO of MSK
Harold Varmus: A Decade of Leadership at MSK

Harold Varmus became President and Chief Executive Officer of Memorial Sloan Kettering Cancer Center on January 1, 2000. He ended his decade-long tenure on July 1, 2010. And on July 12, 2010, Dr. Varmus took up a new role as Director of the National Cancer Institute.
Inherited Mutations May Point to an Aggressive Form of Prostate Cancer

A team of Memorial Sloan Kettering researchers reports that prostate cancer often takes an aggressive course in patients who have inherited mutations in the genes <i>BRCA1</i> or <i>BRCA2</i>.
Doctors operating
New Facility Eases Patient Experience and Promotes Collaborative Treatment and Research

On June 7 when Memorial Sloan Kettering opened a facility housing the novel Center for Image-Guided Interventions, a suite of endoscopy rooms, and new operating rooms for the Surgical Day Hospital.
Ingo Mellinghoff
Researchers Uncover Molecular Interactions in Common Form of Brain Cancer

A multicenter team led by Memorial Sloan Kettering neurologist and researcher Ingo K. Mellinghoff has uncovered the relationship between two proteins that play a critical role in glioblastoma, the most common form of brain cancer.
Charles Sawyers
Charles Sawyers Elected to the National Academy of Sciences

Charles L. Sawyers, Chair of the Human Oncology and Pathogenesis Program, was elected to the National Academy of Sciences at the group's 147th annual meeting in April.
Rendering of a primary tumor mass with adjoining blood vessels (shown in red). Cells that have detached from the tumor and entered the bloodstream (shown as spheres) may circle back to the tumor and enhance its growth and aggressiveness.
Circulating Tumor Cells May Spur Cancer by a Previously Unknown Mechanism

A recent Memorial Sloan Kettering study shows that some circulating tumor cells can circle back and infiltrate their tumor of origin, enhancing its growth and aggressiveness.
Christopher Lima (left) and Derek Tan revealed the mechanism of a key cellular process.
Collaborative Team Advances the Understanding of an Important Activity Inside Cells

A collaborative team of researchers from Memorial Sloan Kettering has determined the mechanism for a biological process that plays a key role in regulating cellular behavior.
Eric Pamer (right) and Joao Xavier
Lucille Castori Center for Microbes, Inflammation, and Cancer Established

Memorial Sloan Kettering has created a new multidisciplinary research center that promises to shed light on the role that microbes and the body's inflammatory and immunological responses to them play in the development of cancer.